Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI) is in Healthcare, Drug Manufacturers - General, based in Italy, listed on Milan. Market cap 11.02B EUR. 52-week range 43.76 to 54.45 EUR. Trailing P/E 22.3. Data as of 2026-10-09.
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops Maapliv for maple syrup urine disease; Isturia for endogenous Cushing's syndrome; Cystadrops treatment of the ocular manifestations of ...